サマリー

骨代謝改善薬の世界市場規模は、2022年の226百万米ドルから2029年には355.1百万米ドルに成長すると予測され、2023年から2029年までのCAGRは6.7％と予測されています。
骨代謝改善薬の米国市場は、2023年から2029年までCAGR %で、2022年の100万米ドルから2029年には100万米ドルに増加すると推定されます。
骨代謝改善剤の中国市場は、2023年から2029年までの年平均成長率で、2022年の百万米ドルから2029年には百万米ドルに増加すると推定されます。
骨代謝改善薬のヨーロッパ市場は、2023年から2029年までのCAGR %で、2022年の百万米ドルから2029年には百万米ドルに増加すると推定されます。
世界の主要な骨代謝改善薬のプレーヤーは、Novartis、Organon、Atnahs Pharma、CTTQ、Jiangsu Hengrui Pharmaceuticals、Nanjing Hencer Pharmaceutical、Chengdu Easton Biopharmaceuticals、 Shenzhen Neptunus PharmaceuticalおよびLuyye Pharmaなどをカバーしています。売上高では、2022年に世界の2大企業がほぼ％のシェアを占めています。
骨代謝改善薬は、骨粗鬆症、パジェット病、骨がんなどの骨関連疾患の治療に使用される医薬品です。これらの薬剤は、骨形成を促進するか、古い骨組織を破壊するプロセスである骨吸収を抑制することで効果を発揮します。
LPI（エルピーアイ）の最新調査レポート「骨代謝改善薬の業界予測」は、2022年の骨代謝改善薬の世界総売上高を過去の売上高から検証し、2023年から2029年の骨代謝改善薬の売上予測について地域や市場分野ごとに包括的に分析しています。骨代謝改善薬の売上を地域別、市場分野別、サブセクター別に分類し、世界の骨代謝改善薬産業の詳細な分析（百万米ドル単位）を提供します。
本インサイトレポートでは、世界の骨代謝改善薬の状況を包括的に分析し、製品区分、会社設立、収益、市場シェア、最新開発、M&A活動に関する主要動向を明らかにしています。また、本レポートでは、骨代謝改善薬のポートフォリオと能力、市場参入戦略、市場ポジション、地理的フットプリントに焦点を当て、加速する世界の骨代謝改善薬市場におけるこれらの企業の独自のポジションをより理解するために、主要グローバル企業の戦略を分析しています。
本インサイトレポートでは、骨代謝改善薬の世界的な見通しを形成する主要な市場動向、推進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別に予測を行い、新たな機会のポケットを明らかにします。何百ものボトムアップの定性的・定量的な市場インプットに基づく透明性の高い手法により、本調査予測は、世界の骨代謝改善薬の現状と将来の軌道について非常にニュアンスのある見解を提供しています。
本レポートでは、骨代謝改善薬市場の製品タイプ、用途、主要メーカー、主要地域、国別の包括的な概要、市場シェア、成長機会について紹介します。
市場のセグメンテーション
タイプ別セグメンテーション
ゾレドロン酸
イバンドロン酸
アレンドロン酸
パミドロン酸
その他
アプリケーション別セグメント
病院
クリニック
その他
また、本レポートでは、市場を地域別に分類しています：
米州
ユーエスエー
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
連邦王国
イタリア
ロシア
中近東・アフリカ
エジプト
南ア
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、企業のカバレッジ、製品ポートフォリオ、市場浸透度を分析した上で選ばれています。
ノバルティス
オルガノン
アットナースファーマ
CTTQ
江蘇亨瑞医薬有限公司
南京ヘンサー製薬
成都イーストン・バイオファーマシューティカルズ
深圳ネプトゥヌス製薬
Luyeファーマ
成都ゴーウェルバイオファーマシューティカル
四川毛龍製薬
本レポートで扱う主な質問
世界の骨代謝改善薬市場の10年後の展望は？
世界および地域別に、骨代謝改善薬市場の成長を促す要因は何か？
市場別、地域別で最も速い成長を遂げる技術は何か？
骨代謝改善薬の市場機会はエンドマーケットの規模によってどのように変化するのか？
骨代謝改善薬のタイプ別、用途別内訳は？
COVID-19とロシア・ウクライナ戦争の影響とは？

ページTOPに戻る

目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bone Metabolism Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Bone Metabolism Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Bone Metabolism Drugs by Country/Region, 2018, 2022 & 2029
2.2 Bone Metabolism Drugs Segment by Type
2.2.1 Zoledronic Acid
2.2.2 Ibandronic Acid
2.2.3 Alendronic Acid
2.2.4 Pamidronic Acid
2.2.5 Other
2.3 Bone Metabolism Drugs Sales by Type
2.3.1 Global Bone Metabolism Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Bone Metabolism Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Bone Metabolism Drugs Sale Price by Type (2018-2023)
2.4 Bone Metabolism Drugs Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Bone Metabolism Drugs Sales by Application
2.5.1 Global Bone Metabolism Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Bone Metabolism Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Bone Metabolism Drugs Sale Price by Application (2018-2023)
3 Global Bone Metabolism Drugs by Company
3.1 Global Bone Metabolism Drugs Breakdown Data by Company
3.1.1 Global Bone Metabolism Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Bone Metabolism Drugs Sales Market Share by Company (2018-2023)
3.2 Global Bone Metabolism Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Bone Metabolism Drugs Revenue by Company (2018-2023)
3.2.2 Global Bone Metabolism Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Bone Metabolism Drugs Sale Price by Company
3.4 Key Manufacturers Bone Metabolism Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bone Metabolism Drugs Product Location Distribution
3.4.2 Players Bone Metabolism Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Bone Metabolism Drugs by Geographic Region
4.1 World Historic Bone Metabolism Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Bone Metabolism Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Bone Metabolism Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Bone Metabolism Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Bone Metabolism Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Bone Metabolism Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Bone Metabolism Drugs Sales Growth
4.4 APAC Bone Metabolism Drugs Sales Growth
4.5 Europe Bone Metabolism Drugs Sales Growth
4.6 Middle East & Africa Bone Metabolism Drugs Sales Growth
5 Americas
5.1 Americas Bone Metabolism Drugs Sales by Country
5.1.1 Americas Bone Metabolism Drugs Sales by Country (2018-2023)
5.1.2 Americas Bone Metabolism Drugs Revenue by Country (2018-2023)
5.2 Americas Bone Metabolism Drugs Sales by Type
5.3 Americas Bone Metabolism Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bone Metabolism Drugs Sales by Region
6.1.1 APAC Bone Metabolism Drugs Sales by Region (2018-2023)
6.1.2 APAC Bone Metabolism Drugs Revenue by Region (2018-2023)
6.2 APAC Bone Metabolism Drugs Sales by Type
6.3 APAC Bone Metabolism Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Bone Metabolism Drugs by Country
7.1.1 Europe Bone Metabolism Drugs Sales by Country (2018-2023)
7.1.2 Europe Bone Metabolism Drugs Revenue by Country (2018-2023)
7.2 Europe Bone Metabolism Drugs Sales by Type
7.3 Europe Bone Metabolism Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bone Metabolism Drugs by Country
8.1.1 Middle East & Africa Bone Metabolism Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Bone Metabolism Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Bone Metabolism Drugs Sales by Type
8.3 Middle East & Africa Bone Metabolism Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bone Metabolism Drugs
10.3 Manufacturing Process Analysis of Bone Metabolism Drugs
10.4 Industry Chain Structure of Bone Metabolism Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bone Metabolism Drugs Distributors
11.3 Bone Metabolism Drugs Customer
12 World Forecast Review for Bone Metabolism Drugs by Geographic Region
12.1 Global Bone Metabolism Drugs Market Size Forecast by Region
12.1.1 Global Bone Metabolism Drugs Forecast by Region (2024-2029)
12.1.2 Global Bone Metabolism Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Bone Metabolism Drugs Forecast by Type
12.7 Global Bone Metabolism Drugs Forecast by Application
13 Key Players Analysis
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Bone Metabolism Drugs Product Portfolios and Specifications
13.1.3 Novartis Bone Metabolism Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Organon
13.2.1 Organon Company Information
13.2.2 Organon Bone Metabolism Drugs Product Portfolios and Specifications
13.2.3 Organon Bone Metabolism Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Organon Main Business Overview
13.2.5 Organon Latest Developments
13.3 Atnahs Pharma
13.3.1 Atnahs Pharma Company Information
13.3.2 Atnahs Pharma Bone Metabolism Drugs Product Portfolios and Specifications
13.3.3 Atnahs Pharma Bone Metabolism Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Atnahs Pharma Main Business Overview
13.3.5 Atnahs Pharma Latest Developments
13.4 CTTQ
13.4.1 CTTQ Company Information
13.4.2 CTTQ Bone Metabolism Drugs Product Portfolios and Specifications
13.4.3 CTTQ Bone Metabolism Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 CTTQ Main Business Overview
13.4.5 CTTQ Latest Developments
13.5 Jiangsu Hengrui Pharmaceuticals
13.5.1 Jiangsu Hengrui Pharmaceuticals Company Information
13.5.2 Jiangsu Hengrui Pharmaceuticals Bone Metabolism Drugs Product Portfolios and Specifications
13.5.3 Jiangsu Hengrui Pharmaceuticals Bone Metabolism Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Jiangsu Hengrui Pharmaceuticals Main Business Overview
13.5.5 Jiangsu Hengrui Pharmaceuticals Latest Developments
13.6 Nanjing Hencer Pharmaceutical
13.6.1 Nanjing Hencer Pharmaceutical Company Information
13.6.2 Nanjing Hencer Pharmaceutical Bone Metabolism Drugs Product Portfolios and Specifications
13.6.3 Nanjing Hencer Pharmaceutical Bone Metabolism Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Nanjing Hencer Pharmaceutical Main Business Overview
13.6.5 Nanjing Hencer Pharmaceutical Latest Developments
13.7 Chengdu Easton Biopharmaceuticals
13.7.1 Chengdu Easton Biopharmaceuticals Company Information
13.7.2 Chengdu Easton Biopharmaceuticals Bone Metabolism Drugs Product Portfolios and Specifications
13.7.3 Chengdu Easton Biopharmaceuticals Bone Metabolism Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Chengdu Easton Biopharmaceuticals Main Business Overview
13.7.5 Chengdu Easton Biopharmaceuticals Latest Developments
13.8 Shenzhen Neptunus Pharmaceutical
13.8.1 Shenzhen Neptunus Pharmaceutical Company Information
13.8.2 Shenzhen Neptunus Pharmaceutical Bone Metabolism Drugs Product Portfolios and Specifications
13.8.3 Shenzhen Neptunus Pharmaceutical Bone Metabolism Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Shenzhen Neptunus Pharmaceutical Main Business Overview
13.8.5 Shenzhen Neptunus Pharmaceutical Latest Developments
13.9 Luye Pharma
13.9.1 Luye Pharma Company Information
13.9.2 Luye Pharma Bone Metabolism Drugs Product Portfolios and Specifications
13.9.3 Luye Pharma Bone Metabolism Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Luye Pharma Main Business Overview
13.9.5 Luye Pharma Latest Developments
13.10 Chengdu Gowell Biopharmaceutial
13.10.1 Chengdu Gowell Biopharmaceutial Company Information
13.10.2 Chengdu Gowell Biopharmaceutial Bone Metabolism Drugs Product Portfolios and Specifications
13.10.3 Chengdu Gowell Biopharmaceutial Bone Metabolism Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Chengdu Gowell Biopharmaceutial Main Business Overview
13.10.5 Chengdu Gowell Biopharmaceutial Latest Developments
13.11 Sichuan Hairong Pharmaceutical
13.11.1 Sichuan Hairong Pharmaceutical Company Information
13.11.2 Sichuan Hairong Pharmaceutical Bone Metabolism Drugs Product Portfolios and Specifications
13.11.3 Sichuan Hairong Pharmaceutical Bone Metabolism Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Sichuan Hairong Pharmaceutical Main Business Overview
13.11.5 Sichuan Hairong Pharmaceutical Latest Developments
14 Research Findings and Conclusion

ページTOPに戻る

図表リスト

List of Tables
Table 1. Bone Metabolism Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Bone Metabolism Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Zoledronic Acid
Table 4. Major Players of Ibandronic Acid
Table 5. Major Players of Alendronic Acid
Table 6. Major Players of Pamidronic Acid
Table 7. Major Players of Other
Table 8. Global Bone Metabolism Drugs Sales by Type (2018-2023) & (K Units)
Table 9. Global Bone Metabolism Drugs Sales Market Share by Type (2018-2023)
Table 10. Global Bone Metabolism Drugs Revenue by Type (2018-2023) & ($ million)
Table 11. Global Bone Metabolism Drugs Revenue Market Share by Type (2018-2023)
Table 12. Global Bone Metabolism Drugs Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global Bone Metabolism Drugs Sales by Application (2018-2023) & (K Units)
Table 14. Global Bone Metabolism Drugs Sales Market Share by Application (2018-2023)
Table 15. Global Bone Metabolism Drugs Revenue by Application (2018-2023)
Table 16. Global Bone Metabolism Drugs Revenue Market Share by Application (2018-2023)
Table 17. Global Bone Metabolism Drugs Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global Bone Metabolism Drugs Sales by Company (2018-2023) & (K Units)
Table 19. Global Bone Metabolism Drugs Sales Market Share by Company (2018-2023)
Table 20. Global Bone Metabolism Drugs Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Bone Metabolism Drugs Revenue Market Share by Company (2018-2023)
Table 22. Global Bone Metabolism Drugs Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers Bone Metabolism Drugs Producing Area Distribution and Sales Area
Table 24. Players Bone Metabolism Drugs Products Offered
Table 25. Bone Metabolism Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Bone Metabolism Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Bone Metabolism Drugs Sales Market Share Geographic Region (2018-2023)
Table 30. Global Bone Metabolism Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Bone Metabolism Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Bone Metabolism Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Bone Metabolism Drugs Sales Market Share by Country/Region (2018-2023)
Table 34. Global Bone Metabolism Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Bone Metabolism Drugs Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Bone Metabolism Drugs Sales by Country (2018-2023) & (K Units)
Table 37. Americas Bone Metabolism Drugs Sales Market Share by Country (2018-2023)
Table 38. Americas Bone Metabolism Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Bone Metabolism Drugs Revenue Market Share by Country (2018-2023)
Table 40. Americas Bone Metabolism Drugs Sales by Type (2018-2023) & (K Units)
Table 41. Americas Bone Metabolism Drugs Sales by Application (2018-2023) & (K Units)
Table 42. APAC Bone Metabolism Drugs Sales by Region (2018-2023) & (K Units)
Table 43. APAC Bone Metabolism Drugs Sales Market Share by Region (2018-2023)
Table 44. APAC Bone Metabolism Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Bone Metabolism Drugs Revenue Market Share by Region (2018-2023)
Table 46. APAC Bone Metabolism Drugs Sales by Type (2018-2023) & (K Units)
Table 47. APAC Bone Metabolism Drugs Sales by Application (2018-2023) & (K Units)
Table 48. Europe Bone Metabolism Drugs Sales by Country (2018-2023) & (K Units)
Table 49. Europe Bone Metabolism Drugs Sales Market Share by Country (2018-2023)
Table 50. Europe Bone Metabolism Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Bone Metabolism Drugs Revenue Market Share by Country (2018-2023)
Table 52. Europe Bone Metabolism Drugs Sales by Type (2018-2023) & (K Units)
Table 53. Europe Bone Metabolism Drugs Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Bone Metabolism Drugs Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Bone Metabolism Drugs Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Bone Metabolism Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Bone Metabolism Drugs Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Bone Metabolism Drugs Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Bone Metabolism Drugs Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Bone Metabolism Drugs
Table 61. Key Market Challenges & Risks of Bone Metabolism Drugs
Table 62. Key Industry Trends of Bone Metabolism Drugs
Table 63. Bone Metabolism Drugs Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Bone Metabolism Drugs Distributors List
Table 66. Bone Metabolism Drugs Customer List
Table 67. Global Bone Metabolism Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Bone Metabolism Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Bone Metabolism Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Bone Metabolism Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Bone Metabolism Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Bone Metabolism Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Bone Metabolism Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Bone Metabolism Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Bone Metabolism Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Bone Metabolism Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Bone Metabolism Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Bone Metabolism Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Bone Metabolism Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Bone Metabolism Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Novartis Basic Information, Bone Metabolism Drugs Manufacturing Base, Sales Area and Its Competitors
Table 82. Novartis Bone Metabolism Drugs Product Portfolios and Specifications
Table 83. Novartis Bone Metabolism Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. Novartis Main Business
Table 85. Novartis Latest Developments
Table 86. Organon Basic Information, Bone Metabolism Drugs Manufacturing Base, Sales Area and Its Competitors
Table 87. Organon Bone Metabolism Drugs Product Portfolios and Specifications
Table 88. Organon Bone Metabolism Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. Organon Main Business
Table 90. Organon Latest Developments
Table 91. Atnahs Pharma Basic Information, Bone Metabolism Drugs Manufacturing Base, Sales Area and Its Competitors
Table 92. Atnahs Pharma Bone Metabolism Drugs Product Portfolios and Specifications
Table 93. Atnahs Pharma Bone Metabolism Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Atnahs Pharma Main Business
Table 95. Atnahs Pharma Latest Developments
Table 96. CTTQ Basic Information, Bone Metabolism Drugs Manufacturing Base, Sales Area and Its Competitors
Table 97. CTTQ Bone Metabolism Drugs Product Portfolios and Specifications
Table 98. CTTQ Bone Metabolism Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. CTTQ Main Business
Table 100. CTTQ Latest Developments
Table 101. Jiangsu Hengrui Pharmaceuticals Basic Information, Bone Metabolism Drugs Manufacturing Base, Sales Area and Its Competitors
Table 102. Jiangsu Hengrui Pharmaceuticals Bone Metabolism Drugs Product Portfolios and Specifications
Table 103. Jiangsu Hengrui Pharmaceuticals Bone Metabolism Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. Jiangsu Hengrui Pharmaceuticals Main Business
Table 105. Jiangsu Hengrui Pharmaceuticals Latest Developments
Table 106. Nanjing Hencer Pharmaceutical Basic Information, Bone Metabolism Drugs Manufacturing Base, Sales Area and Its Competitors
Table 107. Nanjing Hencer Pharmaceutical Bone Metabolism Drugs Product Portfolios and Specifications
Table 108. Nanjing Hencer Pharmaceutical Bone Metabolism Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Nanjing Hencer Pharmaceutical Main Business
Table 110. Nanjing Hencer Pharmaceutical Latest Developments
Table 111. Chengdu Easton Biopharmaceuticals Basic Information, Bone Metabolism Drugs Manufacturing Base, Sales Area and Its Competitors
Table 112. Chengdu Easton Biopharmaceuticals Bone Metabolism Drugs Product Portfolios and Specifications
Table 113. Chengdu Easton Biopharmaceuticals Bone Metabolism Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. Chengdu Easton Biopharmaceuticals Main Business
Table 115. Chengdu Easton Biopharmaceuticals Latest Developments
Table 116. Shenzhen Neptunus Pharmaceutical Basic Information, Bone Metabolism Drugs Manufacturing Base, Sales Area and Its Competitors
Table 117. Shenzhen Neptunus Pharmaceutical Bone Metabolism Drugs Product Portfolios and Specifications
Table 118. Shenzhen Neptunus Pharmaceutical Bone Metabolism Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. Shenzhen Neptunus Pharmaceutical Main Business
Table 120. Shenzhen Neptunus Pharmaceutical Latest Developments
Table 121. Luye Pharma Basic Information, Bone Metabolism Drugs Manufacturing Base, Sales Area and Its Competitors
Table 122. Luye Pharma Bone Metabolism Drugs Product Portfolios and Specifications
Table 123. Luye Pharma Bone Metabolism Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 124. Luye Pharma Main Business
Table 125. Luye Pharma Latest Developments
Table 126. Chengdu Gowell Biopharmaceutial Basic Information, Bone Metabolism Drugs Manufacturing Base, Sales Area and Its Competitors
Table 127. Chengdu Gowell Biopharmaceutial Bone Metabolism Drugs Product Portfolios and Specifications
Table 128. Chengdu Gowell Biopharmaceutial Bone Metabolism Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 129. Chengdu Gowell Biopharmaceutial Main Business
Table 130. Chengdu Gowell Biopharmaceutial Latest Developments
Table 131. Sichuan Hairong Pharmaceutical Basic Information, Bone Metabolism Drugs Manufacturing Base, Sales Area and Its Competitors
Table 132. Sichuan Hairong Pharmaceutical Bone Metabolism Drugs Product Portfolios and Specifications
Table 133. Sichuan Hairong Pharmaceutical Bone Metabolism Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 134. Sichuan Hairong Pharmaceutical Main Business
Table 135. Sichuan Hairong Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Bone Metabolism Drugs
Figure 2. Bone Metabolism Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bone Metabolism Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Bone Metabolism Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Bone Metabolism Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Zoledronic Acid
Figure 10. Product Picture of Ibandronic Acid
Figure 11. Product Picture of Alendronic Acid
Figure 12. Product Picture of Pamidronic Acid
Figure 13. Product Picture of Other
Figure 14. Global Bone Metabolism Drugs Sales Market Share by Type in 2022
Figure 15. Global Bone Metabolism Drugs Revenue Market Share by Type (2018-2023)
Figure 16. Bone Metabolism Drugs Consumed in Hospital
Figure 17. Global Bone Metabolism Drugs Market: Hospital (2018-2023) & (K Units)
Figure 18. Bone Metabolism Drugs Consumed in Clinic
Figure 19. Global Bone Metabolism Drugs Market: Clinic (2018-2023) & (K Units)
Figure 20. Bone Metabolism Drugs Consumed in Other
Figure 21. Global Bone Metabolism Drugs Market: Other (2018-2023) & (K Units)
Figure 22. Global Bone Metabolism Drugs Sales Market Share by Application (2022)
Figure 23. Global Bone Metabolism Drugs Revenue Market Share by Application in 2022
Figure 24. Bone Metabolism Drugs Sales Market by Company in 2022 (K Units)
Figure 25. Global Bone Metabolism Drugs Sales Market Share by Company in 2022
Figure 26. Bone Metabolism Drugs Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Bone Metabolism Drugs Revenue Market Share by Company in 2022
Figure 28. Global Bone Metabolism Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Bone Metabolism Drugs Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Bone Metabolism Drugs Sales 2018-2023 (K Units)
Figure 31. Americas Bone Metabolism Drugs Revenue 2018-2023 ($ Millions)
Figure 32. APAC Bone Metabolism Drugs Sales 2018-2023 (K Units)
Figure 33. APAC Bone Metabolism Drugs Revenue 2018-2023 ($ Millions)
Figure 34. Europe Bone Metabolism Drugs Sales 2018-2023 (K Units)
Figure 35. Europe Bone Metabolism Drugs Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Bone Metabolism Drugs Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa Bone Metabolism Drugs Revenue 2018-2023 ($ Millions)
Figure 38. Americas Bone Metabolism Drugs Sales Market Share by Country in 2022
Figure 39. Americas Bone Metabolism Drugs Revenue Market Share by Country in 2022
Figure 40. Americas Bone Metabolism Drugs Sales Market Share by Type (2018-2023)
Figure 41. Americas Bone Metabolism Drugs Sales Market Share by Application (2018-2023)
Figure 42. United States Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Bone Metabolism Drugs Sales Market Share by Region in 2022
Figure 47. APAC Bone Metabolism Drugs Revenue Market Share by Regions in 2022
Figure 48. APAC Bone Metabolism Drugs Sales Market Share by Type (2018-2023)
Figure 49. APAC Bone Metabolism Drugs Sales Market Share by Application (2018-2023)
Figure 50. China Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Bone Metabolism Drugs Sales Market Share by Country in 2022
Figure 58. Europe Bone Metabolism Drugs Revenue Market Share by Country in 2022
Figure 59. Europe Bone Metabolism Drugs Sales Market Share by Type (2018-2023)
Figure 60. Europe Bone Metabolism Drugs Sales Market Share by Application (2018-2023)
Figure 61. Germany Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Bone Metabolism Drugs Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Bone Metabolism Drugs Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Bone Metabolism Drugs Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Bone Metabolism Drugs Sales Market Share by Application (2018-2023)
Figure 70. Egypt Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Bone Metabolism Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Bone Metabolism Drugs in 2022
Figure 76. Manufacturing Process Analysis of Bone Metabolism Drugs
Figure 77. Industry Chain Structure of Bone Metabolism Drugs
Figure 78. Channels of Distribution
Figure 79. Global Bone Metabolism Drugs Sales Market Forecast by Region (2024-2029)
Figure 80. Global Bone Metabolism Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Bone Metabolism Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Bone Metabolism Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Bone Metabolism Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Bone Metabolism Drugs Revenue Market Share Forecast by Application (2024-2029)